The role of the chronic care model in promoting the management of the patient with rare liver disease

References

• Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977 Apr 08;196(4286):129–136. PubMed PMID: 847460.
   PubMed Web of Science ®Google Scholar
• Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998 Aug-Sep;1(1):2–4. PubMed PMID: 10345255.
   PubMedGoogle Scholar
• Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002 Oct 9;288(14):1775–1779. PubMed PMID: 12365965.
   PubMed Web of Science ®Google Scholar
• Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909–1914. PubMed PMID: 12377092.
   PubMed Web of Science ®Google Scholar
• Soubhi H. Toward an ecosystemic approach to chronic care design and practice in primary care. Ann Fam Med. 2007 May-Jun;5(3):263–269. PubMed PMID: 17548856; PubMed Central PMCID: PMCPMC1886497. eng.
   PubMed Web of Science ®Google Scholar
• Royal College of General Practitioners (RCGP). (Rare diseases). [cited 2017 Jun 20]. Available from: http://www.rcgp.org.uk/clinical-and-research/clinical-resources/rare-diseases.aspx
   Google Scholar
• Rare disease UK. EUROPLAN: UK National Conference Report (2014).
   Google Scholar
• European Commission. (National plans or strategies for rare diseases). [cited 2017 Mar 03]. Available from: http://ec.europa.eu/health/rare_diseases/national_plans/detailed_en
   Google Scholar
• EURORDIS-Rare Diseases Europe. (EURORDIS). [cited 2017 Mar 03]. Available from: http://www.eurordis.org/
   Google Scholar
• Taiwan Foundation of Rare diseases. (Taiwan Foundation of Rare diseases). [cited 2017 Mar 03]. Available from: http://www.tfrd.org.tw/tfrd/
   Google Scholar
• Japanese Patient Association. (Japanese Patient Association). [cited 2017 Mar 03]. Available from: http://www.nanbyo.jp/betusite/J-Apartnership/top.html
   Google Scholar
• Korean Organization for Rare Disorders. (Korean Organization for Rare Disorders). [cited 2017 Mar 03]. Available from: www.kord.or.kr/#
   Google Scholar
• China-Dolls -Centre for rare diseases. (China-Dolls -Centre for rare diseases). [cited 2017 Mar 03]. Available from: http://chinadolls.org.cn/
   Google Scholar
• New Zealand Organisation for Rare Disorders (NZORD). (New Zealand Organisation for Rare Disorders (NZORD)). [cited 2017 Mar 03]. Available from: http://www.nzord.org.nz/
   Google Scholar
• Rare Voices Australia. (Rare Voices Australia) [cited 2017 Mar 03]. Available from: https://www.rarevoices.org.au/
   Google Scholar
• National Organisation for Rare Diseases (NORD). (National Organisation for Rare Diseases). [cited 2017 Mar 03]. Available from: https://rarediseases.org/
   Google Scholar
• World Health Organisation (WHO). (Negotiating prices of drugs for rare diseases). [cited 2017 Mar 03]. Available from: http://www.who.int/bulletin/volumes/94/10/15-163519/en/
   Google Scholar
• Rare Diseases Act. Public Law. Washington: Senate and House of Representatives of Rare Diseases the United States of America. 2002. p. 107–280.
   Google Scholar
• European Commission-Health & Consumer Protection Directorate-General. (Useful information on rare diseases from an EU perspective). 2004 [cited 2017 Jun 13]. Available from: http://ec.europa.eu/health/ph_information/documents/ev20040705_rd05_en.pdf
   Google Scholar
• National Institute of Health (NIH),The Genetic and Rare Diseases Information Center (GARD). [cited 2018 Jun 20]. Available from: https://rarediseases.info.nih.gov/about-gard
   Google Scholar
• Rare Disease UK. (Rare Disease UK). [cited 2016 Dec 12]. Available from: https://rarediseases.info.nih.gov/about-gard
   Google Scholar
• Siminerio LM, Piatt GA, Emerson S, et al. Deploying the chronic care model to implement and sustain diabetes self-management training programs. Diabetes Educ. 2006 Mar-Apr;32(2):253–260. PubMed PMID: 16554429.
   PubMed Web of Science ®Google Scholar
• Stroebel RJ, Gloor B, Freytag S, et al. Adapting the chronic care model to treat chronic illness at a free medical clinic. J Health Care Poor Underserved. 2005 May;16(2):286–296. PubMed PMID: 15937392.
   PubMed Web of Science ®Google Scholar
• Piatt GA, Anderson RM, Brooks MM, et al. 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: results of a randomized controlled trial. Diabetes Educ. 2010 Mar-Apr;36(2):301–309. PubMed PMID: 20200284.
   PubMed Web of Science ®Google Scholar
• Piatt GA, Orchard TJ, Emerson S, et al. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes care. 2006 Apr;29(4):811–817. PubMed PMID: 16567820.
   PubMed Web of Science ®Google Scholar
• Piatt GA, Songer TJ, Brooks MM, et al. Impact of patient level factors on the improvement of the ABCs of diabetes. Patient Educ Couns. 2011 Feb;82(2):266–270. PubMed PMID: 20434290.
   PubMed Web of Science ®Google Scholar
• Khan MA, Evans AT, Shah S. Caring for uninsured patients with diabetes: designing and evaluating a novel chronic care model for diabetes care. J Eval Clin Pract. 2010 Aug;16(4):700–706. PubMed PMID: 20545806.
   PubMed Web of Science ®Google Scholar
• Benedetti R, Flock B, Pedersen S, et al. Improved clinical outcomes for fee-for-service physician practices participating in a diabetes care collaborative. Jt Comm J Qual Saf. 2004 Apr;30(4):187–194. PubMed PMID: 15085784.
   PubMedGoogle Scholar
• Liebman J, Heffernan D, Sarvela P. Establishing diabetes self-management in a community health center serving low-income Latinos. Diabetes Educ. 2007 Jun;33 Suppl 6:132S–138S. PubMed PMID: 17620392.
   PubMed Web of Science ®Google Scholar
• Carter EL, Nunlee-Bland G, Callender C. A patient-centric, provider-assisted diabetes telehealth self-management intervention for urban minorities. Perspect Health Inf Manag. 2011 Jan 01;8:1b. PubMed PMID: 21307985; PubMed Central PMCID: PMCPMC3035826.
   PubMedGoogle Scholar
• Foy R, Eccles MP, Hrisos S, et al. A cluster randomised trial of educational messages to improve the primary care of diabetes. Implement Sci. 2011 Dec 16;6:129. PubMed PMID: 22177466; PubMed Central PMCID: PMCPMC3284425.
   PubMed Web of Science ®Google Scholar
• Glasgow RE, Kurz D, King D, et al. Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med. 2010 Dec;25(12):1315–1322. PubMed PMID: 20714820; PubMed Central PMCID: PMCPMC2988142.
   PubMed Web of Science ®Google Scholar
• Glasgow RE, Nutting PA, King DK, et al. Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care. Diabetes care. 2005 Jan;28(1):33–39. PubMed PMID: 15616230.
   PubMed Web of Science ®Google Scholar
• Goderis G, Borgermans L, Grol R, et al. Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. Diabetes Res Clin Pract. 2010 Apr;88(1):56–64. PubMed PMID: 20047770.
   PubMed Web of Science ®Google Scholar
• Hiss RG, Armbruster BA, Gillard ML, et al. Nurse care manager collaboration with community-based physicians providing diabetes care: a randomized controlled trial. Diabetes Educ. 2007 May-Jun;33(3):493–502. PubMed PMID: 17570880.
   PubMed Web of Science ®Google Scholar
• Schillinger D, Handley M, Wang F, et al. Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial. Diabetes care. 2009 Apr;32(4):559–566. PubMed PMID: 19131469; PubMed Central PMCID: PMCPMC2660485.
   PubMed Web of Science ®Google Scholar
• Smith SA, Shah ND, Bryant SC, et al. Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. Mayo Clinic proceedings. 2008 Jul;83(7):747–757. PubMed PMID: 18613991.
   PubMed Web of Science ®Google Scholar
• Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes care. 2001 Apr;24(4):695–700. PubMed PMID: 11315833.
   PubMed Web of Science ®Google Scholar
• Stuckey HL, Dellasega C, Graber NJ, et al. Diabetes nurse case management and motivational interviewing for change (DYNAMIC): study design and baseline characteristics in the Chronic Care Model for type 2 diabetes. Contemp Clin Trials. 2009 Jul;30(4):366–374. PubMed PMID: 19328244; PubMed Central PMCID: PMCPMC2740652.
   PubMed Web of Science ®Google Scholar
• Siminerio LM, Piatt G, Zgibor JC. Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice. Diabetes Educ. 2005;31(2):225–234. Mar-Apr.
   PubMed Web of Science ®Google Scholar
• Piette JD, Weinberger M, Kraemer FB, et al. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes care. 2001 Feb;24(2):202–208. PubMed PMID: 11213866.
   PubMed Web of Science ®Google Scholar
• Maclean CD, Gagnon M, Callas P, et al. The Vermont diabetes information system: a cluster randomized trial of a population based decision support system. J Gen Intern Med. 2009 Dec;24(12):1303–1310. PubMed PMID: 19862578; PubMed Central PMCID: PMCPMC2787948.
   PubMed Web of Science ®Google Scholar
• Lim S, Kang SM, Shin H, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes care. 2011 Feb;34(2):308–313. PubMed PMID: 21270188; PubMed Central PMCID: PMCPMC3024339.
   PubMed Web of Science ®Google Scholar
• Greenwood DA, Blozis SA, Young HM, et al. Overcoming clinical inertia: a randomized clinical trial of a telehealthremote monitoring intervention using paired glucose testing in adults with Type 2 diabetes. J Med Internet Res. 2015 Jul 21;17(7):e178. PubMed PMID: 26199142; PubMed Central PMCID: PMCPMC4527012.
   PubMed Web of Science ®Google Scholar
• Ralston JD, Hirsch IB, Hoath J, et al. Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes care. 2009 Feb;32(2):234–239. PubMed PMID: 19017773; PubMed Central PMCID: PMCPMC2628685.
   PubMed Web of Science ®Google Scholar
• McMahon GT, Gomes HE, Hickson Hohne S, et al. Web-based care management in patients with poorly controlled diabetes. Diabetes care. 2005 Jul;28(7):1624–1629. PubMed PMID: 15983311; PubMed Central PMCID: PMCPMC1262644.
   PubMed Web of Science ®Google Scholar
• Lyles CR, Harris LT, Le T, et al. Qualitative evaluation of a mobile phone and web-based collaborative care intervention for patients with type 2 diabetes. Diabetes Technol Ther. 2011 May;13(5):563–569. PubMed PMID: 21406018.
   PubMed Web of Science ®Google Scholar
• Faridi Z, Liberti L, Shuval K, et al. Evaluating the impact of mobile telephone technology on type 2 diabetic patients’ self-management: the NICHE pilot study. J Eval Clin Pract. 2008 Jun;14(3):465–469. PubMed PMID: 18373577.
   PubMed Web of Science ®Google Scholar
• Piette JD, Weinberger M, McPhee SJ, et al. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000 Jan;108(1):20–27. PubMed PMID: 11059437.
   PubMed Web of Science ®Google Scholar
• The global PBC study Group. (The global PBC study Group). [ cited 13 Aug 2017]. Available from: http://www.globalpbc.com/
   Google Scholar
• Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology (Baltimore, Md). 2016 Mar;63(3):930–950. PubMed PMID: 26223498.
   PubMed Web of Science ®Google Scholar
• Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients With primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015 Dec;149(7):1804–1812 e4. PubMed PMID: 26261009.
   PubMed Web of Science ®Google Scholar
• Augstein P, Vogt L, Kohnert KD, et al. Outpatient assessment of Karlsburg diabetes management system-based decision support. Diabetes care. 2007 Jul;30(7):1704–1708. PubMed PMID: 17468357.
   PubMed Web of Science ®Google Scholar
• Holbrook A, Thabane L, Keshavjee K, et al. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ: Can Med Assoc J = J de l’Assoc medicale canadienne. 2009 Jul 07;181(1–2):37–44. PubMed PMID: 19581618; PubMed Central PMCID: PMCPMC2704409.
   PubMed Web of Science ®Google Scholar
• Eccles MP, Whitty PM, Speed C, et al. A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial. Implement Sci. 2007 Feb 16;2:6. PubMed PMID: 17306017; PubMed Central PMCID: PMCPMC1804280.
   PubMed Web of Science ®Google Scholar
• Peterson KA, Radosevich DM, O’Connor PJ, et al. Improving Diabetes Care in Practice: findings from the TRANSLATE trial. Diabetes care. 2008 Dec;31(12):2238–2243. PubMed PMID: 18809622; PubMed Central PMCID: PMCPMC2584171.
   PubMed Web of Science ®Google Scholar
• Reisman Y, Gips CH, Lavelle SM. Primary biliary cirrhosis: an electronic diagnostic tool trial based on symptoms, (past) history and signs only, using the European database euricterus. The Euricterus PMG. Hepato-gastroenterology. 1997 Jul-Aug;44(16):1104–1109. PubMed PMID: 9261607; eng.
   PubMedGoogle Scholar
• Consortium UP. (UK-PBC: stratified medicine in primary biliary cholangitis). [cited 2017 Aug 13]. Available from: http://www.uk-pbc.com/
   Google Scholar
• Grant RW, Wald JS, Schnipper JL, et al. Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2008 Sep 08;168(16):1776–1782. PubMed PMID: 18779465; PubMed Central PMCID: PMCPMC3829635.
   PubMedGoogle Scholar
• O’Connor PJ, Crain AL, Rush WA, et al. Impact of an electronic medical record on diabetes quality of care. Ann Fam Med. 2005 Jul-Aug;3(4):300–306. PubMed PMID: 16046561; PubMed Central PMCID: PMCPMC1466905.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998 Jan;33(1):99–103. PubMed PMID: 9489916.
   PubMed Web of Science ®Google Scholar
• Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008;43(10):1232–1240. PubMed PMID: 18609163.
   PubMed Web of Science ®Google Scholar
• Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010 Oct;25(10):1681–1686. PubMed PMID: 20880179.
   PubMed Web of Science ®Google Scholar
• Primo J, Maroto N, Martinez M, et al. Incidence of adult form of autoimmune hepatitis in Valencia (Spain). Acta Gastroenterol Belg. 2009 Oct-Dec;72(4):402–406. PubMed PMID: 20163033.
   PubMed Web of Science ®Google Scholar
• Gronbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014 Mar;60(3):612–617. PubMed PMID: 24326217.
   PubMed Web of Science ®Google Scholar
• Kim D, Eshtiaghpour D, Alpern J, et al. Access to primary care is associated with better autoimmune hepatitis outcomes in an urban county hospital. BMC gastroenterology. 2015 Jul 28;15:91. 10.1186/s12876-015-0318-y. PubMed PMID: 26215250; PubMed Central PMCID: PMCPMC4517362. eng.
   PubMed Web of Science ®Google Scholar
• Seo S, Toutounjian R, Conrad A, et al. Favorable outcomes of autoimmune hepatitis in a community clinic setting. J Gastroenterol Hepatol. 2008 Sep;23(9):1410–1414. PubMed PMID: 18373564; eng.
   PubMed Web of Science ®Google Scholar
• Sockalingam S, Blank D, Abdelhamid N, et al. Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors. J Hepatol. 2012 Dec;57(6):1299–1304. PubMed PMID: 22871503; eng.
   PubMed Web of Science ®Google Scholar
• Varyani F, Card T, Kaye P, et al. The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study. BMC Health Serv Res. 2013 May 01;13:161. PubMed PMID: 23635009; PubMed Central PMCID: PMCPMC3652767. eng.
   PubMed Web of Science ®Google Scholar
• UK-AIH. United Kingdom (Auto-immune Hepatitis (UK-AIH) cohort). [cited 2016 Mar 07]. Available from: http://www.uk-aih.com/
   Google Scholar
• Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: from ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol. 2015 Nov;110(11):1536–1538. PubMed PMID: 26416194; PubMed Central PMCID: PMCPMC4679751.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012 May;56(5):1181–1188. PubMed PMID: 22245904.
   PubMed Web of Science ®Google Scholar
• Jones DE, Sutcliffe K, Pairman J, et al. An integrated care pathway improves quality of life in primary biliary cirrhosis. QJM: monthly journal Association Physicians. 2008 Jul;101(7):535–543. PubMed PMID: 18388154; eng.
   PubMed Web of Science ®Google Scholar
• Rannard A, Buck D, Jones DE, et al. Assessing quality of life in primary biliary cirrhosis. Clin Gastroenterol Hepatol Off clin Pract J Am Gastroenterol Assoc. 2004 Feb;2(2):164–174. PubMed PMID: 15017622.
   PubMed Web of Science ®Google Scholar
• Lasker JN, Sogolow ED, Sharim RR. The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist. J Med Internet Res. 2005 Mar 31;7(1):e10. PubMed PMID: 15829472; PubMed Central PMCID: PMCPMC1550634. eng.
   PubMedGoogle Scholar
• Pearce RM, Jones DE, Newton JL. Development of an evidence-based patient information medium: empowering newly diagnosed patients with primary biliary cirrhosis. J Vis Commun Med. 2011 Mar;34(1):4–13. PubMed PMID: 21381930; eng.
   PubMedGoogle Scholar
• Robinson L, Newton JL, Jones D, et al. Promoting self-management and adherence with strength and balance training for older people with long-term conditions: a mixed-methods study. J Eval Clin Pract. 2014 Aug;20(4):318–326. PubMed PMID: 24761750; eng.
   PubMed Web of Science ®Google Scholar
• Untas A, Boujut E, Corpechot C, et al. Quality of life and illness perception in primary biliary cirrhosis: a controlled cross-sectional study. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):52–58. PubMed PMID: 25132012; eng.
   PubMed Web of Science ®Google Scholar
• Huster D. Wilson disease. Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):531–539. PubMed PMID: 20955957.
   PubMed Web of Science ®Google Scholar
• Ala A, Walker AP, Ashkan K, et al. Wilson’s disease. Lancet. 2007 Feb 3;369(9559):397–408. PubMed PMID: 17276780.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Sengupta N, Lai M, et al. A Decision Support Tool to Reduce Overtesting for Ceruloplasmin and Improve Adherence With Clinical Guidelines. JAMA internal medicine. 2015 Sep;175(9):1561–1562. PubMed PMID: 26029881; eng.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Sengupta N, Lai M, et al. Understanding and reducing ceruloplasmin overuse with a decision support intervention for liver disease evaluation. Am J Med. 2016 Jan;129(1):115.e17–22. PubMed PMID: 26254122; eng.
   Web of Science ®Google Scholar
• Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov;125(5):1364–1369. PubMed PMID: 14598252.
   PubMed Web of Science ®Google Scholar
• Sack C, Phan VA, Grafton R, et al. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohns Colitis. 2012 Apr;6(3):302–310. PubMed PMID: 22405166.
   PubMed Web of Science ®Google Scholar
• Huang V, Mishra R, Thanabalan R, et al. Patient awareness of extraintestinal manifestations of inflammatory bowel disease. J Crohn’s & colitis. 2013 Sep;7(8):e318–24. PubMed PMID: 23265763; eng.
   PubMedGoogle Scholar
• de Serres FJ, Blanco I, Fernandez-Bustillo E. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis. 2007 Dec;67(4):184–208. PubMed PMID: 18309698.
   PubMedGoogle Scholar
• Campos MA, Alazemi S, Zhang G, et al. Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency. Copd. 2009 Feb;6(1):31–40. PubMed PMID: 19229706; eng.
   PubMedGoogle Scholar
• Fromer L. Improving diagnosis and management of alpha-1 antitrypsin deficiency in primary care: translating knowledge into action. Copd. 2010 Jun;7(3):192–198. PubMed PMID: 20486818; eng.
   PubMedGoogle Scholar
• Piitulainen E, Bernspng E, Bjorkman S, et al. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. Eur J Clin Pharmacol. 2003 Jun;59(2):151–156. PubMed PMID: 12728289; eng.
   PubMed Web of Science ®Google Scholar
• Rahaghi F, Ortega I, Rahaghi N, et al. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. Copd. 2009 Feb;6(1):26–30. PubMed PMID: 19229705.
   PubMedGoogle Scholar
• Jain A, McCarthy K, Xu M, et al. Impact of a clinical decision support system in an electronic health record to enhance detection of alpha(1)-antitrypsin deficiency. Chest. 2011 Jul;140(1):198–204. PubMed PMID: 21193532; eng.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Vidal R, Barros-Tizon JC, et al. Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience. Respiratory medicine. 1998 Oct;92(10):1181–1187. PubMed PMID: 9926146; eng.
   PubMed Web of Science ®Google Scholar
• Chorostowska-Wynimko J, Struniawski R, Sliwinski P, et al. The national alpha-1 antitrypsin deficiency registry in Poland. Copd. 2015 May;12 Suppl 1:22–26. PubMed PMID: 25938287.
   PubMedGoogle Scholar
• A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest. 1994 Oct ;106(4): 1223–1232. PubMed PMID: 7924498.
   PubMed Web of Science ®Google Scholar
• McElvaney NG, Stoller JK, Buist AS, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest. 1997 Feb;111(2):394–403. PubMed PMID: 9041988.
   PubMed Web of Science ®Google Scholar
• Chapman K. (Alpha 1 Canadian Registry). 1999 [cited 2017 Mar 16]. Available from: http://www.alpha1canadianregistry.com/currenttrials/
   Google Scholar
• Stoller JK, Brantly M, Fleming LE, et al. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency. Chest. 2000 Sep;118(3):843–848. PubMed PMID: 10988213; eng.
   PubMed Web of Science ®Google Scholar
• Seersholm NJ, Kok-Jensen A, Dirksen A. [Survival of patients with severe alpha 1-antitrypsin deficiency]. Ugeskr Laeger. 1995 Apr 24;157(17):2432–2435. PubMed PMID: 7762099.
   PubMedGoogle Scholar
• Pericleous M, Kelly C, Wang T, et al. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):670–679. PubMed PMID: 28786388.
   PubMed Web of Science ®Google Scholar
• Valayannopoulos V, Malinova V, Honzik T, et al. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. J Hepatol. 2014 Nov;61(5):1135–1142. PubMed PMID: 24993530; PubMed Central PMCID: PMCPmc4203712. eng.
   PubMed Web of Science ®Google Scholar
• Burton BK, Balwani M, Feillet F, et al. A Phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency. N Engl J Med. 2015 Sep 10;373(11):1010–1020. PubMed PMID: 26352813; eng.
   PubMed Web of Science ®Google Scholar
• Balwani M, Breen C, Enns GM, et al. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology (Baltimore, Md). 2013 Sep;58(3):950–957. PubMed PMID: 23348766; PubMed Central PMCID: PMCPmc3728169. eng.
   PubMed Web of Science ®Google Scholar
• Weiss KH, Askari FK, Ferenci P, et al. WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial [abstract]. The International EASL Liver Congress; Amsterdam 2017.
   Google Scholar
• Williams R, Ashton K, Aspinall R, et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. The Lancet. 2015;386(10008):2098–2111.
   PubMed Web of Science ®Google Scholar
• Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014 Nov 29;384(9958):1953–1997. PubMed PMID: 25433429.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Wade JB, Gibson DP, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011 Sep;106(9):1646–1653. PubMed PMID: 21556040; PubMed Central PMCID: PMCPMC3989143. eng.
   PubMed Web of Science ®Google Scholar
• Rakoski MO, McCammon RJ, Piette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology (Baltimore, Md). 2012 Jan;55(1):184–191. PubMed PMID: 21858847; PubMed Central PMCID: PMCPMC3462487. eng.
   PubMed Web of Science ®Google Scholar
• Morando F, Maresio G, Piano S, et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013 Aug;59(2):257–264. PubMed PMID: 23523582; eng.
   PubMed Web of Science ®Google Scholar
• Volk ML, Piette JD, Singal AS, et al. Chronic disease management for patients with cirrhosis. Gastroenterology. 2010 Jul;139(1):14–6.e1. PubMed PMID: 20553725; eng.
   PubMed Web of Science ®Google Scholar
• Beg S, Curtis S, Shariff M. Patient education and its effect on self-management in cirrhosis: a pilot study. Eur J Gastroenterol Hepatol. 2016 May;28(5):582–587. PubMed PMID: 27015016; eng
   PubMed Web of Science ®Google Scholar
• Beste LA, Harp BK, Blais RK, et al. Primary care providers report challenges to cirrhosis management and specialty care coordination. Dig Dis Sci. 2015 Sep;60(9):2628–2635. PubMed PMID: 25732712; eng.
   PubMed Web of Science ®Google Scholar
• Dumitrescu SR, Popescu D, Purcarea VL, et al. The benefits of using Sentinel WebDashboard in medicine: IT solution for monitoring and treatment of patient with liver cirrhosis. J Med Life. 2014 Jun 15;7(2):205–210. PubMed PMID: 25408726; PubMed Central PMCID: PMCPMC4197506. eng.
   PubMedGoogle Scholar
• Gorunescu F, Belciug S. Evolutionary strategy to develop learning-based decision systems. Application to breast cancer and liver fibrosis stadialization. J Biomed Inform. 2014 Jun;49:112–118. PubMed PMID: 24518558; eng.
   PubMed Web of Science ®Google Scholar
• Kanwal F, Kramer J, Asch SM, et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol Off clin Pract J Am Gastroenterol Assoc. 2010 Aug;8(8):709–717. PubMed PMID: 20385251; eng.
   PubMed Web of Science ®Google Scholar
• James OF, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology (Baltimore, Md). 1999 Aug;30(2):390–394. PubMed PMID: 10421645.
   PubMed Web of Science ®Google Scholar
• Kim WR, Lindor KD, Locke GR 3rd, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000 Dec;119(6):1631–1636. PubMed PMID: 11113084.
   PubMed Web of Science ®Google Scholar
• Sood S, Gow PJ, Christie JM, et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology. 2004 Aug;127(2):470–475. PubMed PMID: 15300579.
   PubMed Web of Science ®Google Scholar
• Webb G, Ferguson J, Jones D, et al. Cholestatic liver disease and liver transplantation in the UK: a twenty year review [abstract]. AASLD Presentation San Francisco 2015.
   Google Scholar
• Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 1997 Sep;113(3):884–890. PubMed PMID: 9287980.
   PubMed Web of Science ®Google Scholar
• Rudic JS, Poropat G, Krstic MN, et al. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev. 2012 Dec 12;12:CD000551. Pubmed PMID: 23235576
   Google Scholar
• National Institute for Health and Care Excellence. Obeticholic acid for treating primary biliary cholangitis. Technology appraisal guidance ([TA443]). 2017. [cited 2017 Mar 03]. Available from. https://www.nice.org.uk/guidance/ta443
   Google Scholar
• Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983 Jun;51(3):390–395. PubMed PMID: 6863699.
   PubMed Web of Science ®Google Scholar
• Rajmil L, Perestelo-Perez L, Herdman M. Quality of life and rare diseases. Adv Exp Med Biol. 2010;686:251–272. PubMed PMID: 20824450.
   PubMed Web of Science ®Google Scholar
• Cameron LD, Leventhal H. The self-regulation of health and illness behaviour. London; New York: Routledge;2003 p. xii. 337 p.
   Google Scholar
• Global Genes. (RARE Diseases: Facts and Statistics). [ cited 13 Apr 2017]. Available from: https://globalgenes.org/rare-diseases-facts-statistics/
   Google Scholar